Here, we present a case report of a young never-smoker woman affected by an ALK-positive NSCLC tumor who presented an impressive resistance to sequential treatment with ALK TKIs mediated by YES1 and MYC amplifications in a complex context of EMT and high progressive chromosomal instability. This evidence concerns the gene MYC and non-small cell lung carcinoma.